Using Plexus Design to create chemical space for structure-based drug design
How to make better molecules faster is a key challenge in preclinical drug discovery. At Sprint Bioscience we use fragment-based techniques to quickly find high-quality chemical starting points for our small molecule drug discovery projects. Then, we use structure-based drug design to optimize the compounds towards clinical testing.
In this talk, we will illustrate how Plexus Design is used in our drug design process. With Plexus Design we can efficiently expand and evaluate chemical space, which facilitates the generation of new design ideas.